Search the Newsreel

(VST) Risk Channels and Responsive Allocation

This article analyzes Vistra Corp. (VST) using AI models to provide trading strategies. It highlights a near-term strong sentiment potentially challenging persistent mid and long-term weakness, with support currently being tested. The analysis includes position, momentum breakout, and risk hedging strategies, along with multi-timeframe …

Are Telstra shares a buy, hold, or sell after their full-year results, according to this expert?

Strattec CEO and CFO to present at Midwest IDEAS event Aug. 27

Strattec (Nasdaq: STRT) announced that its President & CEO, Jennifer Slater, and CFO, Matthew Pauli, will present and host investor meetings at the Midwest IDEAS Investor Conference on August 27, 2026. The presentation is scheduled for 9:15 a.m. Central Time and a live audio …

Mistras Group (MG) investor Aspasia Vahaviolos discloses 19.2% ownership stake

Aspasia Vahaviolos has disclosed a 19.2% ownership stake in Mistras Group (MG) through a Schedule 13G/A filing. Her holdings consist of 6,105,650 shares, including 1,794,839 shares held directly and 4,310,811 shares in a grantor retained annuity trust managed by her daughter. This significant stake …

AstraZeneca Stock Leads 3 Cash Flow Picks Trading Below Fair Value

Stratasys Q2 Earnings Call Highlights

Key Points Interested in Stratasys, Ltd.? Here are five stocks we like better. Q2 revenue was $137.6 million, up 3.7% sequentially but essentially flat year over year. Record consumables sales and 12.1% growth in Stratasys Direct offset a decline in system revenue. Management highlighted …

Telstra Stock Slips as A$1 Billion Buyback Meets Profit Miss

This article first appeared on GuruFocus. Telstra Group (TLGPY), Australia's largest telecommunications provider, slipped 0.5% in Thursday's early Australian trading. The market's message was pretty clear: another giant buyback was not enough. Telstra unveiled a fresh A$1 billion repurchase program, but annual attributable profit …

Wall Street Analysts Are Bullish on Top Healthcare Picks

Wall Street analysts are showing bullish sentiment towards two healthcare stocks: Orchestra BioMed Holdings (OBIO) and Adagene (ADAG). H.C. Wainwright reiterated a Buy rating for Orchestra BioMed with a $10.00 price target, while LifeSci Capital maintained a Buy rating for Adagene with an $8.00 …

Stratasys (SSYS) revenue holds near flat as H1 2026 losses and cash outflows rise

Stratasys (SSYS) reported nearly flat revenue for H1 2026, with a slight decrease of 0.3% in Q2 2026 revenue to $137.6 million, primarily due to longer sales cycles affecting systems revenue. The company experienced widened net losses, reaching $40.7 million for the first half …

Strata Critical Medical (SRTA) Q2 2026 Earnings Call Transcript

Stratasys (NASDAQ:SSYS) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

Stratasys Ltd. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SSYS) 2026-08-13

Stratasys Ltd. (NASDAQ: SSYS) published its slide deck in conjunction with its Q2 2026 earnings call. The company reported Q2 EPS of $0.03, beating estimates by $0.02, while revenue of $137.61M missed estimates by $872.25K, representing a 0.35% year-over-year decrease.

Insurance Australia Group Earnings: Australian Retail Strength Offset by Weak New Zealand

Can National Australia Bank (ASX:NAB) Hold Investor Attention as Banking Conditions Continue to Shift?

Vistra Corp (VST) News, Articles, Events & Latest Updates

This article compiles recent news and updates for Vistra Corp (VST), primarily focusing on its Q2 2026 earnings. Key highlights include beating EPS estimates, higher pricing and Lotus assets boosting EBITDA, but derivative losses impacting revenues. Analyst reactions, including Jim Cramer's positive sentiment, and …

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Orchestra BioMed Holdings, Inc. (OBIO) recently reported Q2 results showing revenues significantly below expectations, though statutory losses were in line with forecasts. Analysts have since updated their models, projecting a substantial 99% reduction in 2026 revenues and an increase in per-share losses, indicating a …

Q3 EPS Forecast for Strategic Education Lifted by Analyst

Stratasys Ltd. (SSYS) logs Q2 2026 loss but backs full-year guidance and Markforged deal

Stratasys Ltd. (SSYS) reported a Q2 2026 GAAP net loss of $16.9 million on essentially flat revenue of $137.6 million, but reaffirmed its full-year 2026 revenue guidance of $565–$575 million and Adjusted EBITDA of $25–$30 million. The company expects positive operating cash flow only …

Stratasys Ltd earnings beat by $0.02, revenue fell short of estimates

Stratasys Ltd (NASDAQ: SSYS) reported second-quarter EPS of $0.03, surpassing analyst estimates by $0.02, though its revenue of $137.6M fell short of the consensus estimate of $139.26M. The company provided guidance for FY 2026, projecting EPS between $0.09 and $0.14 and revenue between $565.00M …

Australian Clinical Labs Limited (ASX:ACL) Share Price Rises 1.72% as Stock Trades Within Daily Range

Stratasys: Q2 Earnings Snapshot

National Australia Bank (ASX:NAB) Earnings Financial Dynamics: Market Outlook

Strata Critical Medical, Inc. (SRTA) stock price, news, quote and history

Insurance Australia Group (ASX:IAG) Shares Confront A Sharper Margin Squeeze

Wealthcare Advisory Partners LLC Purchases Shares of 12,112 Astrazeneca Plc $AZN

Wealthcare Advisory Partners LLC acquired 12,112 shares of AstraZeneca Plc, valued at approximately $2.3 million, in the second quarter. This move is part of a broader trend of institutional investors increasing their holdings in the pharmaceutical company, which now has 20.35% institutional ownership. AstraZeneca …

Commonwealth Bank (ASX:CBA) Shares Command A Premium Despite Strong FY26 Profit

Telstra (ASX:TLS) Shares Drift As Buyback And Dividend Challenge Doubts

IAG (ASX:IAG) Sees Over 15M Shares in Trading Volume Surge Following FY26 Insurance Earnings Update

5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call

5 Must-Read Analyst Questions From Astrana Health's Q2 Earnings Call Astrana Health's second quarter was met with a positive market response, as management highlighted several drivers behind the results. The company saw continued demand from payer and provider partners, maturation of value-based care cohorts, …

Yancoal Australia Ltd. (YACAF) Q2 2024 Earnings Report - Results, Call & Slides

Yancoal Australia Ltd. (YACAF) Q4 2023 Earnings Report - Results, Call & Slides

Angel Oak Financial Strategies Income Term Trust offers 10.39% yield but faces sustainability concerns due to weak coverage and volatility.

Angel Oak Financial Strategies Income Term Trust (FINS) offers a high distribution yield of 10.39% and exposure to investment-grade floating-rate community bank debt. However, its weak coverage and return of capital practices raise concerns about long-term sustainability. The fund's leverage and discount/premium fluctuations also …

Astral shares rally 9% as Q1 profit soars 48% YoY; here’s what analysts at CITI, UBS, CLSA said

Insurance Australia Group Ltd (IAUGF) (FY 2026) Earnings Call Highlights: Strong Premium Growth ...

This article first appeared on GuruFocus. Premiums: Grew 7.6% to $18.4 billion, including a 10-month contribution from RACQ; underlying growth was around 2%. Underlying Insurance Profit: Up 2.3% to nearly $1.6 billion ($1.58 billion). Net Profit After Tax: Just over $1 billion. Final Dividend: …

Stratasys Ltd (SSYS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Stratasys (SSYS) Earnings Date and Reports 2026